Amylyx Pharmaceuticals (AMLX) Ownership - Who owns Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AMLX showed earnings on August 07, 2025. You can read more about the earnings report here.